Renal support in acute kidney injury

Lancet

Volumn 368, Issue 9533, 2006, Pages 344-345

  Kellum, John ^a   Palevsky, Paul M ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT THERAPY; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTINUOUS HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; KIDNEY INJURY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; SURVIVAL; TREATMENT OUTCOME;

EID: 33746313964     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(06)69084-3     Document Type: Note

References (14)

1. Schiffl H., Lang S., and Fischer R. Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 346 (2002) 305-310
2. Marshall M., Golper T., Shaver M., Alam M., and Chatoth D. Sustained low-efficiency dialysis for critically ill patients requiring renal replacement therapy. Kidney Int 60 (2001) 777-785
3. Schortgen F., Soubrier N., Delclaux C., et al. Hemodynamic tolerance of intermittent hemodialysis in ICU: usefulness of practice guidelines. Am J Respir Crit Care Med 162 (2000) 197-202
4. Kellum J., Johnson J., Kramer D., Palevsky P., Brady J., and Pinsky M. Diffusive vs convective therapy: effects on mediators of inflammation in patient with severe systemic inflammatory response syndrome. Crit Care Med 26 (1998) 1995-2000
5. Mehta R., and Letteri J. Current status of renal replacement therapy for acute renal failure. Am J Nephrol 19 (1999) 377-382
6. Kellum J., Angus D., Johnson J., et al. Continuous versus intermittent renal replacement therapy. Intensive Care Med 28 (2002) 29-37
7. Mehta R., McDonald B., Gabbai F., et al. Continuous versus intermittent dialysis for acute renal failure (ARF) in the ICU: results from a randomized multicenter trial. Kidney Int 60 (2001) 1154-1163
8. Augustine J., Sandy D., Seifert T., and Paganini E. A randomized controlled trial comparing intermittent with continuous dialysis in patients with ARF. Am J Kidney Dis 44 (2004) 1000-1007
9. Dellinger R., Carlet J., Masur H., et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32 (2004) 858-873
10. Venkataraman R., Kellum J., and Palevsky P. Dosing patterns for continuous renal replacement therapy at a large academic medical center in the United States. J Crit Care 17 (2002) 246-250
11. Uchino S., Fealy N., Baldwin I., Morimatsu H., and Bellomo R. Continuous is not continuous: the incidence and impact of circuit "down-time" on uraemic control during continuous veno-venous haemofiltration. Intensive Care Med 29 (2003) 575-578
12. Vinsonneau C., Camus C., Combes A., et al. Continuous venovenous hemodiafiltration versus intermittent hemodialysis for the treatment of acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre, randomised trial. Lancet 368 (2006) 379-385
13. Ronco C., Bellomo R., Homel P., et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 356 (2000) 26-30
14. Evanson J., Himmelfarb J., Wingard R., et al. Prescribed versus delivered dialysis in acute renal failure patients. Am J Kidney Dis 32 (1998) 731-738